startup
A $435 Million Bet on ‘Reversing Aging’
Source:
inc.com 1 min read
Share
You are reading a summary. The full content is hosted on inc.com.
Biotech startup NewLimit secures a major funding round after claiming a ‘breakthrough discovery’ of a prototype medicine that rewinds cellular aging in the liver.
Read the full article on the original website
External link to inc.com
Related Articles
startup
Scientists Warn a Popular Joint Supplement May Accelerate Your Risk of Cognitive Decline—Here’s What to Know
1 min read •
startup
South Korea’s Floundering Movie Business Turns to AI for Help
1 min read •
startup
Sources: Frank founder Charlie Javice, sentenced in September 2025 to 85 months for defrauding JPMorgan Chase, has been seeking a presidential pardon from Trump (Wall Street Journal)
1 min read •